MedDataX Logo

Evaluation of Immunoregulatory Cells in Hematopoietic Stem Cell Transplant

NCT ID: NCT00179049

Last Updated: 2008-12-15

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Total Enrollment

100 participants

Study Classification

OBSERVATIONAL

Study Start Date

2003-04-30

Study Completion Date

2008-04-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The investigators' hypothesis is that the graft-versus-tumor effect can be enhanced while minimizing the complications of graft-versus-host disease.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Repository: Evaluation of Immunoregulatory Cells in Hematopoietic Stem Cell Transplant

NCT00179075

Hematopoietic Stem Cell Transplantation Graft vs Host Disease
COMPLETED

Donor Regulatory T Cells in Treating Patients With Visceral Acute Graft-versus-Host Disease After Stem Cell Transplant

NCT02526329

Graft Versus Host Disease
WITHDRAWN PHASE1

Chronic GVHD Response Measures Validation

NCT01902576

Graft vs Host Disease
ACTIVE_NOT_RECRUITING

The Prospective Collection, Storage and Reporting of Data on Patients Undergoing Hematopoietic Stem Cell Transplantation Utilizing a Standard Preparative Regimen

NCT01890486

Acute Myelogenous Leukemia Acute Lymphocytic Leukemia Chronic Myelogenous Leukemia +7 more
RECRUITING

Improving Outcomes Assessment in Chronic GVHD

NCT00637689

Chronic Graft Versus Host Disease
ACTIVE_NOT_RECRUITING

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

The investigators' hypothesis is that the graft-versus-tumor effect can be enhanced while minimizing the complications of graft-versus-host disease (GVHD) by determining the qualitative and quantitative changes in T regulatory cells throughout the transplant process. Their understanding of this can lead to new treatment strategies and improved clinical therapeutic implications.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Hematopoietic Stem Cell Transplantation Graft vs Host Disease

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

CASE_ONLY

Study Time Perspective

PROSPECTIVE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Patients 18-70 years old undergoing either autologous transplant or allogeneic transplant for various hematologic conditions

Exclusion Criteria

* Patients \< 18 or \> 70 years old undergoing either autologous transplant or allogeneic transplant
Minimum Eligible Age

18 Years

Maximum Eligible Age

70 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Vanderbilt University

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Vanderbilt University

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Adetola A Kassim, M.D.

Role: PRINCIPAL_INVESTIGATOR

Vanderbilt University

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Vanderbilt University Medical Center

Nashville, Tennessee, United States

Site Status

Countries

Review the countries where the study has at least one active or historical site.

United States

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

BMT 030261

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Phase 1 Infused Donor T Regulatory Cells in Steroid Dependent/Refractory Chronic GVHD
NCT01911039 COMPLETED PHASE1
The Polarization and Expression of Chemokine Receptors of T Help Cell in the Pathogenesis of Acute and Chronic GVHD
NCT00207922 UNKNOWN
Immune Mediated Disorders After Allogeneic Hematopoietic Cell Transplantation
NCT01206309 COMPLETED
In-Vitro Studies in Depletion of Haplotype Mismatched Alloreactive T Cells
NCT00731705 WITHDRAWN
Collecting and Storing Tissue and DNA Samples From Patients Undergoing a Donor Stem Cell Transplant
NCT00900406 COMPLETED
Long-Term Follow-up of People Undergoing Hematopoietic Stem Cell Transplantation
NCT03000244 RECRUITING
Kinetic Analysis of Immune Cells in Blood and Chronic Graft-Versus-Host Disease-Affected Tissues After Allogeneic Hematopoietic Cell Transplantation
NCT07235501 NOT_YET_RECRUITING
Prospective Phase II Study for Assessment of Regulatory Immune Cell Populations After Allogeneic HSCT
NCT00587574 UNKNOWN
Prevalence and Development of Liver Dysfunction in Hematopoietic Stem Cell Transplant
NCT05722210 NOT_YET_RECRUITING
Risk of Hepatitis B Reactivation After Bone Marrow Transplantation With Prior Hepatitis B Virus (HBV) Exposure
NCT01481649 COMPLETED
Complement and Graft-versus-host Disease
NCT01520623 COMPLETED NA
Bridging Pediatric and Adult Biomarkers in Graft-Versus-Host Disease
NCT02194439 COMPLETED
Study of the Complications Associated With Certain Stem Cell Transplants
NCT01919099 COMPLETED
Donor Mesenchymal Stem Cell Infusion in Treating Patients With Acute or Chronic Graft-Versus-Host Disease After Undergoing a Donor Stem Cell Transplant
NCT00361049 COMPLETED PHASE1
Long-term Evaluation and Follow-up Care of Patients Treated With Stem Cell Transplants
NCT00106925 RECRUITING
Clinical Studies of New Model Haploidentical Hematopoietic Stem Cell Transplantation
NCT03423706 UNKNOWN NA
The Application of Novel Identified CD8 Regulatory Precursors in Inducing Immune Tolerance After Allo-HSCT
NCT06864598 ENROLLING_BY_INVITATION
Early Treatment of Acute Graft Versus Host Disease With Bone Marrow-Derived Mesenchymal Stem Cells and Corticosteroids
NCT02379442 TERMINATED PHASE1/PHASE2
Long Term Effects On Recipients of Hematopoietic Stem Cell Transplantation
NCT01629017 RECRUITING
Metagenomics Next-generation Sequencing Approach to Detect Microbial DNA/RNA Overtime in Individuals Undergoing Hematopoietic Stem Cell Transplant
NCT06904053 RECRUITING
Bone Marrow Transplant Studies for Safe and Effective Treatment of Leukemia
NCT00001623 COMPLETED NA
Effect of Stem Cell Infusion Time on aGVHD in Patients With Nonmalignant Hematologic Diseases
NCT06294691 RECRUITING PHASE3
Cognitive, Academic and Psychosocial Functioning in Long-Term Survivors of Pediatric Stem Cell Transplantation
NCT01701492 COMPLETED
Bone Marrow Stromal Cell Infusions for Stem Cell Transplant Complications
NCT01633229 COMPLETED PHASE1
Blood Virome After Haploidentical Hematopoietic Stem Cell Transplantation, a Pilot Study
NCT05622032 COMPLETED